GlassScriptPhysician profile
David G Cohen
NPI 1053653279
$6,165.33
in general payments reported to CMS, 2019-2025
22 companies · $568 in 2025
The $568 reported for 2025 was less than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $4,333 · 2021: $534 · 2022: $249 · 2023: $87.37 · 2024: $395 · 2025: $568.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,049.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,049.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic Vascular, INC. | $4,333.33 | 2019 | |
| Boston Scientific Corporation | $384.74 | 2023-2025 | Avvigo Guidance System, Farapulse, Watchman Access System |
| Abiomed | $277.04 | 2021-2025 | Impella |
| Abbott Laboratories | $267.17 | 2021-2023 | Diamondback Peripheral |
| Inari Medical, INC. | $118.28 | 2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Medtronic, INC. | $110.25 | 2022 | |
| Recor Medical INC | $96.12 | 2025 | Paradise Ultrasound Renal Denervation System |
| Heartflow, INC. | $88.23 | 2024-2025 | |
| E.R. Squibb & Sons, L.L.C. | $65.68 | 2023-2025 | Camzyos, Eliquis |
| Boehringer Ingelheim Pharmaceuticals, INC. | $64.17 | 2022 | |
| Terumo Medical Corporation | $44.31 | 2022-2023 | Glidewire |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $44.23 | 2021 | |
| Biosense Webster, INC. | $43.54 | 2024 | Nuvision Ice Catheter |
| Janssen Pharmaceuticals, INC | $42.79 | 2022 | |
| Zoll Circulation INC | $38.87 | 2025 | Downstream Cartridge, Catheter, Therox Ds2 Console |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Amgen INC. | $30.17 | 2021-2022 | |
| Cardiva Medical, INC. | $25.62 | 2025 | Cardiva Vascade Mvp Xl Vvcs 10-12f |
| Cook Medical LLC | $23.09 | 2025 | Neff |
| Elutia, INC. | $20.92 | 2025 | Ecm Patch,Pouch |
| Pfizer INC. | $20.58 | 2021 | |
| Esperion Therapeutics, INC. | $14.65 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $11.55 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw David Cohen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.